Section Arrow
IBIO.NYSE-M
- iBio
Quotes are at least 15-min delayed:2024/04/19 06:58 EDT
Last
 1.77
-0.12 (-6.35%)
Day High 
1.9 
Prev. Close
1.89 
1-M High
4.98 
Volume 
180.51K 
Bid
1.72
Ask
1.77
Day Low
1.7253 
Open
1.87 
1-M Low
1.05 
Market Cap 
16.09M 
Currency USD 
P/E -- 
%Yield
10-SMA 2.08 
20-SMA 2.14 
50-SMA 1.57 
52-W High 28.2 
52-W Low 1.0214 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-4.50/-0.21
Enterprise Value
19.57M
Balance Sheet
Book Value Per Share
1.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BPTHBio-Path Holdings4.2+0.96+29.63%-- 
JAGXJaguar Health0.1771+0.0122+7.40%-- 
DNAGinkgo Bioworks Holdings0.9246+0.053+6.08%-- 
GERNGeron Corp3.73+0.05+1.36%-- 
OCGNOcugen1.32-0.12-8.33%-- 
Quotes are at least 15-min delayed:2024/04/19 06:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.